(MedPage Today) -- The FDA approved oveporexton (Orzeyful) for the treatment of narcolepsy type 1 (narcolepsy with cataplexy) in adults, the agency announced Wednesday. Oveporexton is a first-in-class orexin treatment that goes beyond symptom...